| 1 | [SID118214] | Active | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID330, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Active | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 330 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID103770557] | Unspecified | Ki | 52 | Inhibition of Streptococcus pneumoniae beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay [AID552785, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 52 [uM] | | BioAssay | Inhibition of Streptococcus pneumoniae beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay | | AID | 552785 | | BioAssay type | Literature | | Target | | | PubMed | 21163660 | | Data Table |  |
|
| 3 | [SID103770557] | Unspecified | Ki | 460 | Inhibition of Astrosclera willeyana recombinant GST-tagged astrosclerin 3 expressed in Escherichia coli BL21-DE3-RIPL cells preincubated for 15 mins measured for 10 to 100 secs by stopped flow CO2 hydration assay [AID647373, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 460 [uM] | | BioAssay | Inhibition of Astrosclera willeyana recombinant GST-tagged astrosclerin 3 expressed in Escherichia coli BL21-DE3-RIPL cells preincubated for 15 mins measured for 10 to 100 secs by stopped flow CO2 hydration assay | | AID | 647373 | | BioAssay type | Literature | | Target | | | PubMed | 22227210 | | Data Table |  |
|
| 4 | [SID103770557] | Unspecified | Ki | 490 | Inhibition of Salmonella Typhimurium carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 [AID598732, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 490 [uM] | | BioAssay | Inhibition of Salmonella Typhimurium carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 | | AID | 598732 | | BioAssay type | Literature | | Target | | | PubMed | 21570835 | | Data Table |  |
|
| 5 | [SID103770557] | Unspecified | Ki | 770 | Inhibition of Salmonella Typhimurium carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 [AID598731, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 770 [uM] | | BioAssay | Inhibition of Salmonella Typhimurium carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 | | AID | 598731 | | BioAssay type | Literature | | Target | | | PubMed | 21570835 | | Data Table |  |
|
| 6 | [SID103770557] | Unspecified | Ki | 890 | Inhibition of Leptonychotes weddellii alpha-carbonic anhydrase after 15 mins by CO2 hydrase assay at pH 7.5 [AID587132, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 890 [uM] | | BioAssay | Inhibition of Leptonychotes weddellii alpha-carbonic anhydrase after 15 mins by CO2 hydrase assay at pH 7.5 | | AID | 587132 | | BioAssay type | Literature | | Target | | | PubMed | 21377369 | | Data Table |  |
|
| 7 | [SID103770557] | Unspecified | Ki | 2700 | Inhibition of Helicobacter pylori alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay [AID677271, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 2700 [uM] | | BioAssay | Inhibition of Helicobacter pylori alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay | | AID | 677271 | | BioAssay type | Literature | | Target | | | PubMed | 22835873 | | Data Table |  |
|
| 8 | [SID103770557] | Unspecified | Ki | 6000 | Inhibition of human carbonic anhydrase 1 after 15 mins by CO2 hydrase assay at pH 7.5 [AID587130, Type: Literature] | Carbonic anhydrase 1 [gi:115449] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 6000 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 1 after 15 mins by CO2 hydrase assay at pH 7.5 | | AID | 587130 | | BioAssay type | Literature | | Target | Carbonic anhydrase 1 [gi:115449] | | PubMed | 21377369 | | Data Table |  |
|
| 9 | [SID103770557] | Unspecified | Ki | 6000 | Inhibition of recombinant human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 [AID598726, Type: Literature] | Carbonic anhydrase 1 [gi:115449] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 6000 [uM] | | BioAssay | Inhibition of recombinant human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 | | AID | 598726 | | BioAssay type | Literature | | Target | Carbonic anhydrase 1 [gi:115449] | | PubMed | 21570835 | | Data Table |  |
|
| 10 | [SID103770557] | Unspecified | Ki | 8300 | Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay [AID677270, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 8300 [uM] | | BioAssay | Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay | | AID | 677270 | | BioAssay type | Literature | | Target | | | PubMed | 22835873 | | Data Table |  |
|
| 11 | [SID103770557] | Unspecified | Ki | 200000 | Inhibition of recombinant human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 [AID598728, Type: Literature] | Carbonic anhydrase 2 [gi:115456] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 200000 [uM] | | BioAssay | Inhibition of recombinant human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.3 | | AID | 598728 | | BioAssay type | Literature | | Target | Carbonic anhydrase 2 [gi:115456] | | PubMed | 21570835 | | Data Table |  |
|
| 12 | [SID103770557] | Unspecified | Ki | 200000 | Inhibition of human carbonic anhydrase 2 after 15 mins by CO2 hydrase assay at pH 7.5 [AID587131, Type: Literature] | Carbonic anhydrase 2 [gi:115456] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | Ki | 200000 [uM] | | BioAssay | Inhibition of human carbonic anhydrase 2 after 15 mins by CO2 hydrase assay at pH 7.5 | | AID | 587131 | | BioAssay type | Literature | | Target | Carbonic anhydrase 2 [gi:115456] | | PubMed | 21377369 | | Data Table |  |
|
| 13 | [SID103770557] | Unspecified | | | Inhibition of acid-induced matriptase activation in human 184A1N4 cells using mAb M24 after 20 mins by Western blotting [AID632430, Type: Literature] | Suppressor of tumorigenicity 14 protein [gi:13124575] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Inhibition of acid-induced matriptase activation in human 184A1N4 cells using mAb M24 after 20 mins by Western blotting | | AID | 632430 | | BioAssay type | Literature | | Target | Suppressor of tumorigenicity 14 protein [gi:13124575] | | PubMed | 21966950 | | Data Table |  |
|
| 14 | [SID103770557] | Unspecified | | | Inhibition of acid-induced matriptase activation in human 184A1N4 cells using mAb M69 after 20 mins by Western blotting [AID632431, Type: Literature] | Suppressor of tumorigenicity 14 protein [gi:13124575] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Inhibition of acid-induced matriptase activation in human 184A1N4 cells using mAb M69 after 20 mins by Western blotting | | AID | 632431 | | BioAssay type | Literature | | Target | Suppressor of tumorigenicity 14 protein [gi:13124575] | | PubMed | 21966950 | | Data Table |  |
|
| 15 | [SID103770557] | Unspecified | | | Inhibition of acid-induced matriptase activation in human 184A1N4 cells using mAb M69 after 20 mins by cell-based ELISA-like assay [AID632432, Type: Literature] | Suppressor of tumorigenicity 14 protein [gi:13124575] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Inhibition of acid-induced matriptase activation in human 184A1N4 cells using mAb M69 after 20 mins by cell-based ELISA-like assay | | AID | 632432 | | BioAssay type | Literature | | Target | Suppressor of tumorigenicity 14 protein [gi:13124575] | | PubMed | 21966950 | | Data Table |  |
|
| 16 | [SID103770557] | Unspecified | | | Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset [AID588209, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset | | AID | 588209 | | BioAssay type | Literature | | Target | | | PubMed | 20553011 | | Data Table |  |
|
| 17 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia [AID625279, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia | | AID | 625279 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 18 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis [AID625280, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis | | AID | 625280 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 19 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis [AID625281, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis | | AID | 625281 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 20 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis [AID625282, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis | | AID | 625282 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 21 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests [AID625283, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests | | AID | 625283 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 22 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure [AID625284, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure | | AID | 625284 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 23 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis [AID625285, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis | | AID | 625285 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 24 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis [AID625286, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis | | AID | 625286 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 25 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly [AID625287, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly | | AID | 625287 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 26 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice [AID625288, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice | | AID | 625288 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 27 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease [AID625289, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease | | AID | 625289 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 28 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty [AID625290, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty | | AID | 625290 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 29 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal [AID625291, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal | | AID | 625291 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 30 | [SID103770557] | Unspecified | | | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score [AID625292, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103770557 | | CID | 5234 | | Outcome | Unspecified | | BioAssay | Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score | | AID | 625292 | | BioAssay type | Literature | | Target | | | PubMed | 22194678 | | Data Table |  |
|
| 31 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice [AID200, Type: other] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice | | AID | 200 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU BALB/C (nude) mice [AID208, Type: other] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU BALB/C (nude) mice | | AID | 208 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon Carcinoma 38 (subcutaneous) in B6C3F1 mice [AID214, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon Carcinoma 38 (subcutaneous) in B6C3F1 mice | | AID | 214 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 [AID220, Type: other] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 | | AID | 220 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intravenous) in B6C3F1 mice [AID276, Type: other] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intravenous) in B6C3F1 mice | | AID | 276 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Amelanotic Melanoma (LOX) (intraperitoneal) in NU/NU BALB/C (nude) mice [AID280, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Amelanotic Melanoma (LOX) (intraperitoneal) in NU/NU BALB/C (nude) mice | | AID | 280 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID118214] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma M5076 (intraperitoneal) in B6C3F1 mice [AID292, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma M5076 (intraperitoneal) in B6C3F1 mice | | AID | 292 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID48414457] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 48414457 | | CID | 5234 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results | | AID | 1189 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID48414457] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity [AID1194, Type: other] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 48414457 | | CID | 5234 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity | | AID | 1194 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID48414457] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results [AID1199, Type: other] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 48414457 | | CID | 5234 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results | | AID | 1199 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID48414457] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 48414457 | | CID | 5234 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results | | AID | 1205 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID48414457] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 48414457 | | CID | 5234 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results | | AID | 1208 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID118214] | Inconclusive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice [AID298, Type: other] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inconclusive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice | | AID | 298 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID118214] | Inconclusive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice [AID266, Type: other] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 118214 | | CID | 5234 | | Outcome | Inconclusive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice | | AID | 266 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|